1. 13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Issue 8 (23rd March 2015) Authors: De Montalembert, Mariane; Abboud, Miguel R.; Fiquet, Anne; Inati, Adlette; Lebensburger, Jeffrey D.; Kaddah, Normeen; Mokhtar, Galila; Piga, Antonio; Halasa, Natasha; Inusa, Baba; Rees, David C.; Heath, Paul T.; Telfer, Paul; Driscoll, Catherine; Al Hajjar, Sami; Tozzi, Alberto; Jiang, Qin; Emini... Journal: Pediatric blood & cancer Issue: Volume 62:Issue 8(2015:Aug.) Page Start: 1427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 13‐valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6‐17 years of age with sickle cell disease previously vaccinated with 23‐valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. Issue 8 (23rd March 2015) Authors: De Montalembert, Mariane; Abboud, Miguel R.; Fiquet, Anne; Inati, Adlette; Lebensburger, Jeffrey D.; Kaddah, Normeen; Mokhtar, Galila; Piga, Antonio; Halasa, Natasha; Inusa, Baba; Rees, David C.; Heath, Paul T.; Telfer, Paul; Driscoll, Catherine; Al Hajjar, Sami; Tozzi, Alberto; Jiang, Qin; Emini... Journal: Pediatric blood & cancer Issue: Volume 62:Issue 8(2015:Aug.) Page Start: 1427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency. Issue 1 (28th November 2018) Authors: Bianchi, Paola; Fermo, Elisa; Glader, Bertil; Kanno, Hitoshi; Agarwal, Archana; Barcellini, Wilma; Eber, Stefan; Hoyer, James D.; Kuter, David J.; Maia, Tabita Magalhães; Mañu‐Pereira, Maria del Mar; Kalfa, Theodosia A.; Pissard, Serge; Segovia, José‐Carlos; van Beers, Eduard; Gallagher, Patrick ... Journal: American journal of hematology Issue: Volume 94:Issue 1(2019:Jan.) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ChemInform Abstract: Opportunity Knocks: Organic Chemistry for Fragment‐Based Drug Discovery (FBDD). Issue 10 (February 2016) Authors: Murray, Christopher W.; Rees, David C. Journal: ChemInform Issue: Volume 47:Issue 10(2016) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combined blood transfusion and hydroxycarbamide in children with sickle cell anaemia. (1st November 2012) Authors: Brousse, Valentine; Gandhi, Shreyans; de, Mariane; Height, Sue; Dick, Moira C.; O'Driscoll, Sandra; Abihsera, Gaëlle; Rees, David C. Journal: British journal of haematology Issue: Volume 160:Number 2(2013:Jan.) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cost‐effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the TAPS trial. (12th December 2013) Authors: Spackman, Eldon; Sculpher, Mark; Howard, Jo; Malfroy, Moira; Llewelyn, Charlotte; Choo, Louise; Hodge, Renate; Johnson, Tony; Rees, David C.; Fijnvandraat, Karin; Kirby‐Allen, Melanie; Davies, Sally; Williamson, Lorna Journal: European journal of haematology Issue: Volume 92:Number 3(2014:Mar.) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. C–H functionalisation tolerant to polar groups could transform fragment-based drug discovery (FBDD). Issue 36 (1st September 2021) Authors: Chessari, Gianni; Grainger, Rachel; Holvey, Rhian S.; Ludlow, R. Frederick; Mortenson, Paul N.; Rees, David C. Journal: Chemical science Issue: Volume 12:Issue 36(2021) Page Start: 11976 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Design and synthesis of dihydroisoquinolones for fragment-based drug discovery (FBDD). Issue 5 (7th January 2016) Authors: Palmer, Nick; Peakman, Torren M.; Norton, David; Rees, David C. Journal: Organic & biomolecular chemistry Issue: Volume 14:Issue 5(2016) Page Start: 1599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso‐Occlusive Events) trial: A global Phase 3 double‐blind, randomized, placebo‐controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy. Issue 2 (24th September 2015) Authors: Hoppe, Carolyn C.; Styles, Lori; Heath, Lori E.; Zhou, Chunmei; Jakubowski, Joseph A.; Winters, Kenneth J.; Brown, Patricia B.; Rees, David C.; Heeney, Matthew M. Journal: Pediatric blood & cancer Issue: Volume 63:Issue 2(2016) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Determinants of severity in sickle cell disease. (November 2022) Authors: Rees, David C.; Brousse, Valentine A.M.; Brewin, John N. Journal: Blood reviews Issue: Volume 56(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗